Clinical research is medical and health research that involves people, their data, or their biological samples to produce knowledge about human disease, treatment, and prevention. It spans a wide range of activities, from testing a new drug in a hospital to tracking health patterns across large populations. What separates it from routine medical care is its primary goal: clinical practice aims to benefit the individual patient sitting in front of a doctor, while clinical research aims to generate knowledge that will benefit future patients.
What Clinical Research Covers
The scope of clinical research is broader than most people realize. It’s not limited to drug trials. The National Institutes of Health defines clinical research as a continuum that includes studies on disease mechanisms, drug and device development, clinical trials, prevention and health promotion, behavioral research, epidemiology, health services research (including cost-effectiveness), and community-based trials. If a study involves interactions with patients, populations, or diagnostic data and is designed to improve understanding of human health, it falls under the clinical research umbrella.
Within that umbrella, there are two fundamental study types. Interventional studies, commonly called clinical trials, assign participants to receive a specific treatment, behavior change, or device so researchers can measure what happens. Observational studies don’t assign any intervention at all. Instead, researchers collect information about people’s health, habits, or environments as they naturally occur. Observational designs include cohort studies (following a group over time), case-control studies (comparing people with a condition to those without), and community-level studies. Both types contribute essential evidence, but they answer different kinds of questions.
How It Differs From Standard Medical Care
The line between clinical research and clinical practice can seem blurry, especially when both happen in the same hospital. The core distinction is intent. In clinical practice, the doctor tailors a care plan to benefit you specifically and can adjust it based on clinical judgment. In clinical research, the study protocol dictates the care plan, and the goal is to produce generalizable knowledge for people in the future.
This difference shapes what participants should expect. A patient visiting their doctor expects to receive benefit from treatment. A research participant, by contrast, should understand they may or may not receive direct benefit. Treatment plans in research follow a fixed protocol rather than being customized on the fly. Changes require approval from oversight bodies, not just a physician’s judgment call. Researchers are never supposed to promise a therapeutic response from participation.
How Research Endpoints Work
Every clinical study is built around endpoints: specific, pre-defined measures that tell researchers whether an intervention worked. The primary endpoint addresses the main research question and determines how many participants the study needs to produce reliable results. A cancer drug trial, for example, might use overall survival or tumor shrinkage as its primary endpoint.
Secondary endpoints assess additional questions. These might measure quality of life, side effects, or alternative markers of disease control. Choosing the right endpoints matters enormously because they determine what the study can actually prove. A study that picks a weak or irrelevant endpoint can generate misleading results even if the underlying data is solid.
Ethical Protections for Participants
Clinical research involving people is governed by layered ethical safeguards that developed largely in response to historical abuses. The Belmont Report, a foundational U.S. policy document, established three core principles that still guide every study today. The first is respect for persons: individuals must be treated as autonomous decision-makers, and people with reduced capacity for autonomy (such as children or cognitively impaired adults) deserve additional protection. The second is beneficence, which requires researchers to minimize possible harms and maximize possible benefits. The third is justice, meaning the burdens and benefits of research must be distributed fairly. Researchers cannot recruit only vulnerable populations for risky studies or offer promising treatments only to favored groups.
Internationally, the Declaration of Helsinki sets similar standards. It requires that any study involving human participants only proceed if the importance of the objective outweighs the risks and burdens to participants. It also mandates that studies be registered in a publicly accessible database before the first participant is enrolled, and that results, including negative and inconclusive findings, be published. Funding sources and conflicts of interest must be disclosed.
The Role of Institutional Review Boards
Before any clinical research can begin, it must be reviewed and approved by an Institutional Review Board, or IRB. An IRB is a formally designated group that evaluates research protocols, informed consent documents, and related materials to protect the rights and welfare of human participants. The FDA requires IRBs to verify that risks to participants are minimized and that those risks are reasonable compared to anticipated benefits. An IRB has the authority to approve a study, require modifications, or reject it outright. It also monitors ongoing research and can suspend a study if problems emerge. Only the full committee can formally disapprove a research proposal.
What Informed Consent Requires
Informed consent is not just a signature on a form. It’s a process designed to ensure that anyone entering a study does so voluntarily and with a clear understanding of what’s involved. Federal regulations require that the consent process include a description of all reasonably foreseeable risks or discomforts, along with an explicit statement that participation is voluntary. You can refuse to participate without any penalty or loss of benefits you’d otherwise receive, and you can withdraw at any time for any reason.
Investigators must also seek consent under circumstances that give people genuine time to consider whether they want to participate. The setting has to minimize the possibility of coercion or pressure. For example, a doctor who is also a researcher cannot imply that a patient’s standard care will suffer if they decline to join a study.
Registration and Transparency Requirements
In the United States, federal law requires certain clinical studies to be registered on ClinicalTrials.gov. The requirement applies to what the law calls “applicable clinical trials,” which include controlled clinical investigations (beyond phase 1) of FDA-regulated drugs or biological products, and certain studies of FDA-regulated medical devices. These rules apply to trials with at least one site in the U.S., trials conducted under an FDA investigational application, or trials involving products manufactured in the U.S. and exported for research.
Registration must happen before the first participant is recruited. This prevents a practice called publication bias, where researchers conduct studies but only publish results that support their hypothesis. By requiring registration upfront, regulators and the public can track whether a study was completed and whether its results were ever reported. Pediatric postmarket surveillance studies for medical devices also fall under these requirements.